IDBI Healthcare Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 12-08-2020

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
S&P BSE Health Care - TRI 15.44 26.34 51.80 15.04 2.32 14.27

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 59.42 22.71 8.89 2.07 3,496.33
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 59.56 14.22 3.76 2.43 1,284.30
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 60.54 16.83 4.97 2.81 541.76

Fund Holdings as on 31-July-2020

  • Dr. Reddy's Laboratories Ltd.

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Cipla Ltd.

  • IPCA Laboratories Ltd.

  • TREPS

  • Aurobindo Pharma Ltd.

  • Lupin Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Natco Pharma Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Abbott India Ltd.

  • Dr. Lal Path labs Ltd.

  • Alkem Laboratories Ltd.

  • Cadila Healthcare Ltd.

  • Pfizer Ltd.

  • Laurus Labs Ltd.

  • Sanofi India Ltd.

  • Syngene International Ltd.

  • Aarti Industries Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • ICICI Lombard General Insurance Company Ltd.

  • Biocon Ltd.

  • HDFC Life Insurance Company Ltd.

  • Aster DM Healthcare Ltd.

  • Ajanta Pharma Ltd.

  • Metropolis Healthcare Ltd.

  • AstraZeneca Pharma India Ltd.

  • Net Receivable / Payable

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Insurance

  • Chemicals

View More

Fund Manager

  • Cash

  • Equity

View More

About IDBI Healthcare Fund

Scheme Analysis

IDBI Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to IDBI Mutual Fund. It was launched on 28-Feb-2019 and currently has an AUM of ₹41.05 crore. IDBI Healthcare Fund is benchmarked against S&P BSE Health Care - TRI as primary index.

The NAV of IDBI Healthcare Fund ended down ₹-0.16(-1.05%)yesterday to ₹15.08.

Among its top 3 holdings the fund has exposure to Dr. Reddy's Laboratories Ltd., and

The IDBI Healthcare Fund is managed by Uma Venkatraman .

Fund House Contact

5th floor, Mafatlal Centre, Nariman Point Mumbai - 400021

022-6644 2800
022-6644 2802